Adherence to the Highest Standards of Manufacturing
Our manufacturing sites have been designed to operate in compliance with Good Manufacturing Practice (GMP) standards adopted by the U.S. Food & Drug Administration (FDA), the China National Medical Products Administration (NMPA) and European Medicines Agency (EMA).
Manufacturing Facilities
We are advancing a pipeline consisting of novel oral small molecules and monoclonal antibodies for cancer. BeiGene is also working to create combination solutions aimed at having both a meaningful and lasting impact on cancer patients. We have one marketed product in the U.S. and five marketed products in China, including two internally-developed ones.